Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
NGM Biopharmaceuticals
3200
NGM Biopharmaceuticals
Health Care
Medical
Technology
Biotechnology
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Suggest edits
Founded
2007
Raised
$295.4M
Follow us
Also headquartered in South San Francisco
Genentech
insitro
MyoKardia
Sutro Biopharma
Freenome
SuccessFactors
Plenty
Theravance
Cytokinetics, Inc.
Dispatch
Companies in the same industry
Desktop Genetics
Transplant
HiberGene Diagnostics
Centauri Therapeutics Limited
Prospective Research
Hua Medicine
Beijing Gene+ Technology
TopGene
BioNTech AG
EnCare Biotech
Alexa global traffic share
Overview
Funding
5
Add info
Latest funding
Show all
$57,500,000
Venture capital (Series D) - 2015
$105,999,996
Venture capital (Series E) - 2015
Team Size
1–10
Employees
I work here
Location
South San Francisco
,
United States
Headquarters
Explore South San Francisco
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when NGM Biopharmaceuticals makes some noise.
